Credit Agricole S A Heron Therapeutics, Inc. Transaction History

Credit Agricole S A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $2.41 Million - $3.73 Million	-142,200 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $909,100 - $1.11 Million	39,270 Added 38.15%	142,200 $3.48 Million
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $784,047 - $1.14 Million	35,590 Added 52.85%	102,930 $2.67 Million
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $949,200 - $1.29 Million	31,640 Added 88.63%	67,340 $2.13 Million
Q2 2018 Aug 10, 2018	BUY	$26.4 - $42.0 $712,800 - $1.13 Million	27,000 Added 310.34%	35,700 $1.39 Million
Q1 2018 May 14, 2018	BUY	$18.43 - $28.8 $160,341 - $250,560	8,700 New	8,700 $240,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.